T he regenerative capacity of adult human hearts after infarction seems vestigial at best, perhaps because of the poor proliferative capacity of terminally differentiated cardiomyocytes and desecration of the local environment that would otherwise be conducive of stem cellmediated repair or loss of stem cells, or both. In a recent edition of the journal Science, Porello et al set a new benchmark in this field by showing that the hearts of neonatal mice have, in contrast, an impressive regenerative capacity after surgical resection, albeit one that is lost almost immediately as cardiomyocytes exit the cell cycle and mature.
In a technical tour de force, Porello et al 1 report that day 1 neonatal mice subjected to resection of the apex of the left ventricle (amounting to ϳ15% of the ventricular myocardium) not only survive but also show complete regeneration of the myocardium and restoration of cardiac function. Furthermore, they provide evidence that the predominant mechanism involved is not differentiation of stem cells, but transient dedifferentiation and proliferation of cardiomyocytes in both the border and remote zones of the heart. In contrast, resection of a lesser amount of apical myocardium in day 7 neonates, at a time after terminal differentiation of cardiomyocytes has already taken place, resulted in markedly increased mortality and failure of myocardial regeneration, with wound repair by scar formation only.
It has long been known that in adult mammals, the heart is one of the least regenerative organs in the body. As a result, repair after massive tissue injury, as occurs with myocardial infarction, is limited to replacement of the myocardium by dense collagenous scar tissue. This impairs contractile function, resulting in adverse remodelling and, in severe cases, ventricular dilation, heart failure, and death. To explore if intracardiac grafting of cardiomyocytes might be useful to promote myocardial repair, some 17 years ago, Field and colleagues 2 implanted transgenic cardiomyocytes from embryonic day-15 mice, which harboured a fusion gene construct of the ␣-cardiac myosin heavy chain with a ␤-galactosidase reporter, into the hearts of adult syngeneic hosts. In this elegant proof-of-principle study, they showed that these fetal cells, when delivered directly into the myocardium, engrafted; displayed prolonged survival; formed connections with the host myocardium via intercalated discs; and expressed the transgene. Such plasticity of growth, albeit in the context of transplantation of cells into the myocardium of a host animal, is perhaps not surprising given the continued hyperplastic growth of the myocardium during development-plasticity that can fully compensate for loss of up to 50% of cardiomyocytes during the embryonic/fetal period. 3 The replicative competence of cardiomyocytes in the prenatal period in mammals is in stark contrast to their terminal differentiation that commences shortly after birth, as observed in detailed analyses of rat and mouse hearts by Gerdes and coworkers 4 and Field and colleagues. 5 They showed rapid conversion of cardiomyocytes from hyperplastic to hypertrophic growth in the perinatal period, with cessation of cell division after 4 days of age. This was coincident with the onset of binucleation (in rodents) and polyploidy, resulting from a period of continued DNA synthesis in the absence of cytokinesis. Indeed, the replicative ability of mammalian terminally differentiated cardiomyocytes in the injury setting, such as during myocardial infarction, seems trivially small. 5 This terminal state is not observed, however, in certain nonmammalian species, including teleost fish, like Zebrafish, and urodeles, such as newts, which show a high basal level of cardiomyocyte division and sustained cardiomyocyte regeneration, even in adult life, in response to injury. Indeed, complete repair of the myocardium resulting from a stem cell-independent mechanism, involving cell cycle reentry and proliferation of cardiomyocytes, has been demonstrated in Zebrafish after apical resection of at least 20% of the left ventricle 6 or after cryoinjury. 7 Although the findings of Porello et al 1 confirm the known plasticity of embryonic/fetal cardiomyocytes and their terminal differentiation perinatally, the study is nonetheless of importance, both clinically in terms of enhancing myocardial repair and preserving cardiac contractile function after injury, and mechanistically in terms of delineating the molecular pathways underlying myocardial wound healing.
From a clinical point of view, it will be relevant to determine if complete repair of the myocardium in the day-1 neonates is possible not only after a relatively atraumatic injury such as apical resection, but also after an injury resulting in a hostile inflammatory environment, as occurs after myocardial infarction. In this regard, it is of interest that in Zebrafish, myocardial repair after cryoinjury, 7 which incites vigorous inflammation, involves marked scar formation, which is nonetheless replaced by regenerated myocardium, albeit after a protracted period, compared with regeneration in the surgical resection model,
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Commentaries which lacks the inflammatory surge. Even in this highly regenerative species, however, the newly generated cardiomyocytes did not appear to integrate functionally. More important, of course, is elucidating the mechanism of cardiomyocyte terminal differentiation, with the view to interdicting the pathways involved to allow restoration of proliferative competence and, thus, complete functional repair of the adult heart. Whether this process involves an intrinsic cell cycle block, a loss of mitogenic stimuli, or both is presently unclear. Numerous studies have attempted to drive cardiomyocytes into cell division by overexpression of cell cycle activators, for example, cyclin D1, by inactivation of cell cycle inhibitors, or by expression of telomerase to prevent telomere shortening with continued cell division. This resulted in cardiomyocytes undergoing an extra round or two of cell division, but then, nonetheless, exiting the cell cycle, despite continuation of the stimulus. That said, it is interesting that Keating and colleagues reported that administration of the cytokine, fibroblast growth factor-1, together with an inhibitor of the proapoptotic p38MAPK pathway, stimulates division of mature cardiomyocytes by a mechanism involving initial sarcomere dedifferentiation and then cell proliferation, 8 as also observed by Porello et al. 1 Proliferation of mature cardiomyocytes has also been reported by Kühn and colleagues 9 with activation of the Erb receptor tyrosine kinase pathway by neuregulin-1, a compound also know to stimulate myofibrillogenesis and to have salutory survival and cardiac contractile effects in a variety of myocardial injury models. 10 Finally, Li et al 11 showed that expression of the stem cell factor receptor, c-kit, known mostly in the heart as a marker of multipotent progenitor cells, is also activated transiently in cardiomyocytes in the perinatal period, before waning exactly at the time when the cardiomyocytes are exiting the cell cycle and becoming binucleated. This suggests that c-kit signalling is an important stimulus for cardiomyocyte cell cycle exit, a notion supported by the finding that cardiomyocyte-specific overexpression of a signalling-inactive dominant negative c-kit mutant allows continued hyperplasic cardiomyocyte growth in adult animals. 11 Clearly, the events set in motion in cardiomyocytes shortly after birth cause a cell memory response, suggesting prolonged alterations in the transcriptional activity of gene networks. Whether this response is immutable after its induction and, thus, resistant to subsequent blockade of the pathways involved or, rather, can be reprogrammed to allow complete repair of the myocardium by proliferation of mature cardiomyocytes in the adult heart remains unclear. Nevertheless, given that microRNAs (miRNAs) influence large gene networks, it is interesting that Porello et al 12 have now begun to search for miRNAs that regulate terminal differentiation and have found a candidate, miRNA-195 (a member of the miR-15 family), whose expression is markedly enhanced at the time of cardiomyocyte cell cycle withdrawal. This is not altogether surprising, given that miRNA-195, which is expressed in mammals but not other vertebrates, 13 is known to regulate G1 to S phase cell cycle progression via an effect on the expression of cyclins. 14, 15 The other aspect of the Porello et al 1 study of interest is that while a contribution of stem or progenitor cell differentiation cannot be excluded, their lineage-tracing experiments are in keeping with cardiomyocyte proliferation underlying the regenerative response. Nevertheless, given that unlike the heart injury response in Zebrafish, repair of mammalian hearts appears to involve cardiac stem recruitment and maturation, 16 further studies will be required to more fully assess their potential contribution in the myocardial woundhealing response in this and other models, as well as in humans.
The contribution of Porello et al 1 provides an important link in the progression of cardiac regenerative medicine. Although the clinical significance remains to be seen, it is noteworthy that the amount of attention being directed at what appears to be a vestigial tissue regenerative response to ischemic injury in adult mammals is truly remarkable. This is because only the most ardent pessimist would commit the possibility of a clinically significant, integrated myocardial repair response in humans to a cul-de-sac of history. The science surrounding organ regeneration is rich and diverse, and we anticipate many new advances in the near future.
